Skip to content
zameds

Ketorolac

Schedule 3 to 4, conditions apply
Loading the molecular structure
C15H13NO3255.27 g/mol

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3826.

Listing

Schedules
Schedule 3 to 4, conditions apply
Source
Consolidated Schedules 06 July 2026

Registered medicines

1 registered product listed

Counted through the register's ingredient index, which does not reach every record.

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
KetorolacTora-dol, Acular, Toraket, +1 more0,4 %, 1 %, 3 %, 5 mg/ml, +3 more4 applicants8 registrationsS3

1 more registered product name Ketorolac in their active ingredient

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
Sabax KetorolacSabax ketorolac30, 60Adcock Ingram Critical Care (Pty) Ltd2 registrations
KeloptKeloptNot statedGen-eye (Pty) Ltd451033
AcuvailAcuvail4,5 mg/mlAbbvie (Pty) Ltd470336
OflaectOflaect15, 30, 60Hetero Drugs South Africa (Pty) Ltd3 registrations
Bedoral CancelledBedoral30 mgRanbaxy Pharmaceutical (Pty) LtdA400147S4

Regulatory status

Where S3 to S4 sits on the scale

Depends on which listing applies

At the least restrictive, Schedule 3: needs a doctor's prescription, dispensed by a pharmacist. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.

Schedule S3 to S4, as the Consolidated Schedules list it.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Ketorolac

  • S4: Ketorolac

    • except when intended for ophthalmic use.

    Consolidated Schedules 06 July 2026, line 6848

  • S3: Ketorolac

    • when intended for ophthalmic use.

    Consolidated Schedules 06 July 2026, line 3860

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles